Casgevy
Casgevy
2024 Driver Revealed: Charles River’s Game-Changing Casgevy
BIOT
📰🚀 Charles River sees Casgevy as crucial driver for 2024! 🌟 Stay tuned for the latest updates! 📆🔍
World’s First CRISPR Cell Therapy Approved for Sickle Cell – Solvias to Perform Testing
BIOT
📰 Solvias will perform release testing on CASGEVY, the world's first CRISPRCas9 genome-edited cell therapy. 🧪💊🔬✅🌍
Vertex Launches Casgevy: Revolutionary Gene Editing for Genetic Diseases
BIOT
📚 Vertex Pharmaceuticals launches Casgevy, targeting gene editing therapies for sickle cell disease and beta thalassemia. 💰 This move strengthens Vertex's position in genetic diseases and aims for significant impact in the field.
